External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Haematology Blood Coagulation Disorder

Blood Coagulation Disorder

What's new

Sign up or login to unlock the full suite of MEDICALLY features
Oct 20 / Roche
Multicentre performance evaluation and reference ranges for an immunoassay for the quantitative determination of Factor XIII antigen on the cobas t 711 analyser
In this poster, the authors present the results of the analytical performance of the FXIII immunoassay on the cobas t 711 analyser.
Haematology Blood coagulation disorder APSTH-2023

Sign up or login to unlock the full suite of MEDICALLY features
Oct 20 / Roche
Multicentre performance evaluation and reference ranges for the quantitative determination of Factor IX activity on the cobas t 711 analyser
In this poster, the authors present the results of the analytical performance of the one-stage aPTT-type FIX assay on the cobas t 711 analyser.
Haematology Blood coagulation disorder APSTH-2023

Sign up or login to unlock the full suite of MEDICALLY features
Dec 1 / Roche
Method comparison of eight coagulation assays on the cobas t 411 versus cobas t 511/t 711 analysers
The aim of the study was to investigate comparability between the cobas t 411 and cobas t 511 /t 711 platforms when performing screening and coagulation tests.
Haematology Blood coagulation disorder APSTH-2021

Sign up or login to unlock the full suite of MEDICALLY features
Dec 1 / Roche
Multicenter performance evaluation and reference range determination for a new assay for the quantitative evaluation of factor VIII in citrated plasma
The aim of the study was to evaluate the analytical performance of a new one stage aPTT based FVIII assay for the quantitative assessment of FVIII activity on the cobas t 711 analyzer.
Haematology Blood coagulation disorder ISTH-2020

Sign up or login to unlock the full suite of MEDICALLY features
Nov 22 / Roche
Impact of characteristic inhibition kinetics of different FVIII inhibitors on the inhibitor titer quantification in the modified Nijmegen-Bethesda Assay
The aim of the study was to analyze the impact of different FVIII inhibitor kinetics on the titer calculation in the modified Nijmegen-Bethesda assay applying different criteria.
Haematology Blood coagulation disorder ISTH-2021

Sign up or login to unlock the full suite of MEDICALLY features
Nov 22 / Roche
Analytical performance of a modified one-stage clotting assay for measuring emicizumab on cobas t 511 / t 711 analyzers
The aim of the study was to evaluate the analytical performance of the emicizumab assay when used on cobas t 511 and cobas t 711 analysers.
Haematology Blood coagulation disorder ISTH-SSC-2019

Ask a question or share feedback

Get in touch

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.